Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection: what are the challenges?

导出原文传递

翻译打印收藏纠错

作者： Vena, Antonio ^[1] ; Castaldo, Nadia ^[2] ; Magnasco, Laura ; Bavastro, Martina ; Limongelli, Alessandro ; Giacobbe, Daniele Roberto ; Bassetti, Matteo

作者单位： Clin Malattie Infett,Osped Policlin San Martino IRCCS ^[1] Dept Pulm,Azienda Sanit Univ Integrata Udine ^[2]

关键词 MRSA PVL community-acquired cephalosporins oxazolidinones fluoroquinolones lipoglycopeptides tetracyclines lefamulin ACUTE BACTERIAL SKIN PANTON-VALENTINE LEUKOCIDIN SINGLE-DOSE ORITAVANCIN INDUCIBLE CLINDAMYCIN RESISTANCE COMPARING CEFTOBIPROLE MEDOCARIL VANCOMYCIN PLUS AZTREONAM GRAM-POSITIVE INFECTIONS ONCE-WEEKLY DALBAVANCIN IN-VITRO ACTIVITIES DOUBLE-BLIND

发布时间 2023-06-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert opinion on pharmacotherapy

2023年24卷1/6期

331-346页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection: what are the challenges?

Expert opinion on pharmacotherapy

相似文献

Expert opinion on pharmacotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection: what are the challenges?

Expert opinion on pharmacotherapy

相似文献

Expert opinion on pharmacotherapy

相关期刊

检索历史清除